(HealthDay News) – A software monitoring program that tracks implantable cardioverter-defibrillator lead function could detect problems with the devices earlier than current monitoring processes.

Please provide your email address to receive an email when new articles are posted on . The FDA approved an extravascular ICD system to treat tachycardia that may cause sudden cardiac arrest. Placing ...

SALT LAKE CITY--(BUSINESS WIRE)-- Healthcare reform, new compliance regulations, and the move to outcomes-based payment are putting pressure on clinical documentation and coding processes at hospitals ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA approved its next-generation Bluetooth-capable implantable cardioverter ...

World’s Only Completely Subcutaneous Implantable Defibrillator Provides Protection for Patients at Risk for Sudden Cardiac Arrest Without Touching the Heart SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- ...

Innovative device offers first-line treatment for patients at risk of sudden cardiac arrest MARLBOROUGH, Mass., Boston Scientific Corporation has received FDA and CE Mark approval of the EMBLEM™ ...